How to Motivate Your Monkey
Our September issue reports the discontinuation of the human trials Avigen was conducting on a new hemophilia treatment–the latest of many setbacks in the commercialization of gene therapy. But basic research in the field has continued undaunted, with results that may strike you as either astounding or terrifying, depending on how you feel about the prospect of genetically modifying your personality.
Researchers at the National Institute of Mental Health have used gene therapy to “cure” monkeys of their tendency to procrastinate. Similar treatments could eventually benefit people suffering from depression, schizophrenia, and obsessive-compulsive disorder; but they could also take the debate about the “medicalization” of psychological characteristics into a whole new arena.
Keep Reading
Most Popular
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.